Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity
Yingzhong Li, Zhijun Su, Weiyu Zhao, et al.
Nature Cancer (2020) Vol. 1, Iss. 9, pp. 882-893
Open Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Lipid nanoparticles for mRNA delivery
Xucheng Hou, Tal Zaks, Róbert Langer, et al.
Nature Reviews Materials (2021) Vol. 6, Iss. 12, pp. 1078-1094
Open Access | Times Cited: 2167
Interleukins in cancer: from biology to therapy
Daria Briukhovetska, Janina Dörr, Stefan Endres, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 8, pp. 481-499
Open Access | Times Cited: 537
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Ignacio Melero, Eduardo Castañón, Maite Álvarez, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 9, pp. 558-576
Open Access | Times Cited: 341
Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8 + T cell response
Jinjin Chen, Zhongfeng Ye, Changfeng Huang, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 34
Open Access | Times Cited: 243
mRNA-based cancer therapeutics
Chuang LIU, Qiangqiang Shi, Xiangang Huang, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 526-543
Closed Access | Times Cited: 215
An Update on Self-Amplifying mRNA Vaccine Development
Anna K. Blakney, Shell Ip, Andrew J. Geall
Vaccines (2021) Vol. 9, Iss. 2, pp. 97-97
Open Access | Times Cited: 192
Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy
Jin-Qing Liu, Chengxiang Zhang, Xinfu Zhang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 306-313
Open Access | Times Cited: 148
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
Edo Kon, Nitay Ad‐El, Inbal Hazan‐Halevy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 739-754
Open Access | Times Cited: 133
Engineering cytokine therapeutics
Jeroen Deckers, Tom Anbergen, Ayla M. Hokke, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 286-303
Open Access | Times Cited: 114
Innate Immunity and Cancer Pathophysiology
Laura Maiorino, Juliane Daßler‐Plenker, Lijuan Sun, et al.
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 425-457
Open Access | Times Cited: 106
Nanomedicine for brain cancer
Sabina Quader, Kazunori Kataoka, Horacio Cabral
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114115-114115
Open Access | Times Cited: 99
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
Yash Agarwal, Lauren E. Milling, Jason Y.H. Chang, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 2, pp. 129-143
Open Access | Times Cited: 96
Engineering interferons and interleukins for cancer immunotherapy
Patrick G. Holder, Shion A. Lim, Christine Huang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114112-114112
Open Access | Times Cited: 95
Novel strategies exploiting interleukin-12 in cancer immunotherapy
Assunta Cirella, Carlos Luri‐Rey, Claudia Augusta Di Trani, et al.
Pharmacology & Therapeutics (2022) Vol. 239, pp. 108189-108189
Closed Access | Times Cited: 82
Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity
Mengrui Liu, Shiqi Hu, Na Yan, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 4, pp. 565-575
Closed Access | Times Cited: 82
An Overview of Nanoparticle Protein Corona Literature
Mohammad Javad Hajipour, Reihaneh Safavi‐Sohi, Shahriar Sharifi, et al.
Small (2023) Vol. 19, Iss. 36
Open Access | Times Cited: 64
mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy
Fengqiao Li, Xue‐Qing Zhang, William Ho, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 63
Strategies for non-viral vectors targeting organs beyond the liver
Jeonghwan Kim, Yulia Eygeris, Renee C. Ryals, et al.
Nature Nanotechnology (2023) Vol. 19, Iss. 4, pp. 428-447
Closed Access | Times Cited: 53
From structural design to delivery: mRNA therapeutics for cancer immunotherapy
Feng Zhou, Lujia Huang, Shiqin Li, et al.
Exploration (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 48
Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy
Yuebao Zhang, Xucheng Hou, Shi Du, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 11, pp. 1364-1374
Closed Access | Times Cited: 47
STING Agonist-Derived LNP-mRNA Vaccine Enhances Protective Immunity Against SARS-CoV-2
Yuebao Zhang, Jinyue Yan, Xucheng Hou, et al.
Nano Letters (2023) Vol. 23, Iss. 7, pp. 2593-2600
Open Access | Times Cited: 46
LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing
Yonger Xue, Yuebao Zhang, Yichen Zhong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 33
Enhancing in situ cancer vaccines using delivery technologies
Ningqiang Gong, Mohamad‐Gabriel Alameh, Rakan El‐Mayta, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 607-625
Closed Access | Times Cited: 25
Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy
Shufen Xu, Yue Xu, Nicholas C. Solek, et al.
Advanced Materials (2024) Vol. 36, Iss. 29
Closed Access | Times Cited: 24
Antiangiogenic Therapeutic mRNA Delivery Using Lung-Selective Polymeric Nanomedicine for Lung Cancer Treatment
Ngoc Duy Le, Bảo Lộc Nguyễn, Basavaraj R. Patil, et al.
ACS Nano (2024) Vol. 18, Iss. 11, pp. 8392-8410
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top